⚡ Quick Start — If You Read Nothing Else
The 7 most important things to know right now.
- Early intervention is life-changing. Diagnosing and supporting an autistic child during the first few years of life — when the brain is most adaptable — can significantly improve communication, social skills, and long-term outcomes. Do not “wait and see.”
- Autism is a spectrum. Support needs range from individuals requiring around-the-clock care to those living independently with minimal support. Every autistic person is unique, with individual strengths, challenges, and goals.
- Medications treat co-occurring conditions, not autism itself. There is no medication that treats the core features of autism. Medications like risperidone and aripiprazole are FDA-approved specifically for irritability associated with ASD — not for autism as a whole. Other medications address ADHD, anxiety, insomnia, or seizures that commonly co-occur.
- Behavioral and developmental therapies are the foundation. Evidence-based interventions such as Applied Behavior Analysis (ABA), the Early Start Denver Model (ESDM), and JASPER have the strongest research support for improving core challenges.
- Educational rights are powerful tools. Under federal law (IDEA), children with autism are entitled to a free appropriate public education, including an Individualized Education Program (IEP) or Section 504 plan tailored to their needs.
- Autism is a lifelong condition. With the right supports, many autistic individuals thrive across the lifespan. Planning for adolescence, transition to adulthood, employment, and independent living should begin early.
- Diagnostic disparities exist. Girls and women, racial and ethnic minorities, and adults are systematically under-diagnosed. If you suspect autism in yourself or a family member, advocate for a thorough evaluation regardless of age, sex, or background.
Understanding Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by differences in social communication and interaction, along with restricted or repetitive patterns of behavior, interests, or activities. It is called a “spectrum” because the way autism presents varies enormously from person to person — in type, intensity, and combination of traits.
Autism is not a disease to be cured. It is a fundamental aspect of how a person’s brain is wired, present from early development. Many autistic individuals and advocacy organizations prefer identity-first language (“autistic person”) over person-first language (“person with autism”), though both are used and respected in this guide.
The current best estimate from the CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network is approximately 1 in 31 children in the United States, based on 2022 surveillance, published 2025. This represents an increase from previous estimates, driven largely by improved identification in historically underdiagnosed groups including girls, Black, Hispanic, and Asian children. For the first time, autism prevalence among minority children slightly exceeds that in White children, reflecting better screening reach rather than a true increase in occurrence.
Autism has strong genetic roots. Twin studies show heritability estimates of 80–90%, and hundreds of genes have been implicated. In approximately 20–25% of cases, a specific genetic cause can be identified through testing (chromosomal microarray, fragile X testing, or whole exome sequencing).
Environmental factors also contribute, typically interacting with genetic predisposition. Established risk factors include advanced parental age, very premature birth, low birth weight, and prenatal exposure to certain medications (notably valproate). Ongoing research examines the roles of prenatal immune activation, pollution, and other environmental exposures.
Vaccines do not cause autism. This has been studied extensively in millions of children across multiple countries. The original 1998 paper suggesting a link was fraudulent and was retracted. Multiple large-scale studies have definitively shown no association between any vaccine and autism.
The term “spectrum” is often misunderstood as a simple line from “mild” to “severe.” In reality, autism varies across multiple dimensions simultaneously: social communication ability, sensory sensitivity, repetitive behavior patterns, cognitive functioning, language development, motor skills, and co-occurring conditions.
The DSM-5-TR describes three severity levels based on support needs:
- Level 1 (“Requiring support”): Noticeable difficulties in social communication without support; inflexibility of behavior causes significant interference in some contexts.
- Level 2 (“Requiring substantial support”): Marked deficits in verbal and nonverbal social communication; limited initiation of social interactions; restricted/repetitive behaviors obvious to casual observers.
- Level 3 (“Requiring very substantial support”): Severe deficits in communication; very limited initiation of social interaction; extreme difficulty coping with change; great distress when routines are interrupted.
These levels can shift over time with intervention and development. An individual may also be Level 1 in one domain and Level 2 or 3 in another. The previous diagnostic labels of Asperger syndrome, PDD-NOS, and autistic disorder were folded into the single ASD diagnosis in the DSM-5 (2013).
Autism rarely exists in isolation. The majority of autistic individuals have at least one co-occurring condition, and many have several:
- ADHD: 50–70% of autistic individuals (the most common co-occurring condition)
- Anxiety disorders: 40–50%
- Sleep disorders: 50–80% (insomnia is extremely common)
- Epilepsy/seizures: 20–30% (higher in those with intellectual disability)
- Intellectual disability: approximately 30–40%
- Gastrointestinal problems: constipation, diarrhea, and feeding difficulties are very common
- Depression: especially in adolescents and adults
- Motor difficulties: coordination problems, low muscle tone
Treating co-occurring conditions often produces the most dramatic improvement in quality of life. For example, addressing sleep problems or treating ADHD can lead to significant improvements in behavior, attention, and family functioning.
Much of what looks puzzling from the outside makes sense once you understand the autistic experience from the inside, and that shift in perspective is one of the most useful things a family can develop. Two themes explain a great deal. The first is sensory difference: roughly nine in ten autistic people experience the sensory world more intensely or differently — a fluorescent light that hums unbearably, a clothing tag that feels like sandpaper, a noisy classroom that is genuinely painful, or a craving for deep pressure and movement. Behaviors that seem random — covering ears, refusing certain foods or clothes, spinning, rocking — are often sensible responses to a sensory world that is too much or not enough. The second is communication and predictability: many autistic people process language more literally, need more time to respond, and find unexpected change genuinely distressing because predictability is how they manage an overwhelming world. Repetitive behaviors and routines (sometimes called stimming) are frequently self-regulation — ways of calming and coping — not things to be stopped for their own sake. When you read a behavior as communication or coping rather than as misbehavior, you respond more effectively and your child feels understood. Asking "what is this behavior telling me, and what need is behind it?" is more productive than asking "how do I make it stop?"
The period right after a diagnosis can carry a complicated mix of feelings — relief at finally having an explanation, grief for imagined futures, worry, guilt, and sometimes a sense of being overwhelmed by information and appointments. All of these are common and valid, and feeling grief does not mean you love your child any less or see them as less whole. A few things help. Give yourself permission to feel whatever you feel without judging it, and know that most parents describe the early shock settling into a steadier, more hopeful footing over time. Resist the urge to solve everything at once; the diagnosis is the start of a plan, not an emergency to be fixed in a week, and the highest-value early steps are simply to connect with early intervention and a knowledgeable care team. Beware the flood of online "miracle" claims that prey on exactly this vulnerable moment — lean instead on reputable organizations and other families who have walked this path. Perhaps most importantly, your child is the same child they were the day before the diagnosis; what has changed is that you now have a framework and a community to help you understand and support them. Many parents, looking back, describe the diagnosis not as the loss they first feared but as the beginning of finally understanding their child.
Getting a Diagnosis
An autism diagnosis can feel overwhelming, but it is the essential first step toward accessing effective support and services. Diagnosis involves screening, comprehensive evaluation, and often additional medical workup. The earlier autism is identified, the sooner evidence-based interventions can begin — and early intervention during critical developmental windows can make a meaningful difference.
Signs of autism can appear as early as 6–12 months of age, though they are most commonly recognized between 12 and 24 months. Key early signs include:
- Limited or no eye contact
- Not responding to their name by 12 months
- Not pointing or waving by 12 months
- Limited babbling or vocalizations
- No single words by 16 months or two-word phrases by 24 months
- Loss of previously acquired language or social skills at any age (regression)
- Limited interest in other children or shared play
- Unusual repetitive movements (hand flapping, spinning, rocking)
- Intense focus on specific objects or topics
- Distress with changes in routine
- Unusual sensory responses (covering ears, avoiding certain textures)
Important: Not every child shows all of these signs, and some of these behaviors may occur in typically developing children. The pattern, frequency, and intensity matter more than any single behavior. Girls may present differently — they often mask or camouflage social difficulties, leading to later or missed diagnosis.
Screening is a brief check to determine whether a child needs a full diagnostic evaluation. The most widely used tool is:
- M-CHAT-R/F (Modified Checklist for Autism in Toddlers, Revised with Follow-Up): A parent-completed questionnaire for children aged 16–30 months. Available free online. Sensitivity is approximately 83–85%, meaning it catches most but not all cases. A positive screen does not mean a child has autism — it means a comprehensive evaluation is warranted.
The AAP recommends universal screening at 18 and 24 months of age, with additional screening at any age if concerns arise. Some children are not identified until school age or even adolescence, particularly girls, children with milder presentations, and children from underserved communities.
A positive screen or clinical concern leads to a comprehensive diagnostic evaluation, typically performed by a developmental pediatrician, child psychologist, child psychiatrist, or multidisciplinary team. The evaluation includes:
- ADOS-2 (Autism Diagnostic Observation Schedule, 2nd Edition): A semi-structured, standardized assessment considered the gold-standard observational tool. The evaluator engages the individual in social interactions and play while observing communication, social interaction, and behavior patterns.
- ADI-R (Autism Diagnostic Interview, Revised): A structured parent/caregiver interview covering developmental history and current behaviors.
- Developmental/cognitive testing: IQ testing or developmental assessment to evaluate intellectual functioning and adaptive skills.
- Vineland Adaptive Behavior Scales (Vineland-3): Measures practical daily living skills, communication, and socialization.
- Speech-language assessment: Evaluates receptive and expressive language abilities.
- Medical evaluation: Hearing test (audiometry), vision screening, and consideration of genetic testing.
Wait times for evaluation can be long — often 6–12 months or more. During the waiting period, families should access early intervention services (which can often begin based on developmental delay, before a formal autism diagnosis). In Utah, the Baby Watch program serves children from birth to age 3 based on developmental concerns, regardless of diagnosis.
Many autistic adults were not diagnosed in childhood, particularly women, people of color, and those with average or above-average intellectual ability who learned to “mask” their differences. Adult diagnosis is becoming increasingly recognized and valued.
Seeking diagnosis as an adult can be validating — providing an explanation for lifelong differences and opening access to supports and accommodations. The evaluation process for adults involves clinical interview, developmental history (often from parents or early records), self-report questionnaires, and sometimes observational assessment.
In Utah, the University of Utah Neurobehavior HOME Program offers adult autism evaluations. Finding clinicians experienced with adult ASD diagnosis may require some research, but the effort is worthwhile.
Significant disparities exist in who gets diagnosed with autism and when:
- Sex/gender: Boys are diagnosed approximately 3.4 times more often than girls, but this ratio likely reflects under-identification in girls rather than true prevalence differences. Girls more often present with “internalizing” features (anxiety, social withdrawal) rather than “externalizing” ones (behavioral disruption), and they tend to camouflage social difficulties more effectively.
- Race/ethnicity: Historically, Black, Hispanic, and Asian children were diagnosed later and less often than White children. Recent CDC data (2025) shows this gap is narrowing, with prevalence rates now slightly higher in some minority groups — reflecting improved screening, not increased occurrence.
- Socioeconomic status: Families with fewer resources face greater barriers to diagnosis and services.
Clinicians and families should be aware of these disparities and advocate for thorough evaluation whenever concerns exist, regardless of demographics.
The wait for a formal diagnostic evaluation can stretch six to twelve months or longer, and that gap is genuinely frustrating — but it does not have to be wasted time, because the single most important thing you can do does not require the diagnosis at all. Start early intervention now. In Utah and most states, a child can receive evaluation and services through the early-intervention system (Baby Watch, 1-800-961-4226, for birth to age 3) or preschool special education based on developmental concern alone, with no autism diagnosis required — and these are exactly the months when intervention helps most. Beyond that, use the wait to prepare: keep a simple log of your concerns with dates and examples (short videos of behaviors you want the evaluator to see can be invaluable), gather any early records, get a hearing test arranged (ruling out hearing loss is a standard early step), and learn about your insurance coverage and local services so you can move quickly once the diagnosis arrives. Connect with a parent organization (the Utah Parent Center offers free guidance) and, if it helps, with other families. It is also reasonable to ask to be placed on cancellation lists and to seek evaluation through more than one pathway (a developmental pediatrician, a psychologist, or the school system) in parallel. Treating the wait as preparation time rather than dead time means that when the diagnosis comes, you are ready to act — and your child has not lost the intervening months.
- What screening tool are you using, and what do the results mean?
- What kind of specialist should do the comprehensive evaluation?
- What can we do while we wait for the evaluation appointment?
- Should my child be referred to early intervention services now?
- What specific tests will be part of the evaluation (ADOS-2, cognitive testing, hearing)?
- Should genetic testing be done, and what would it tell us?
- How were co-occurring conditions assessed (ADHD, anxiety, sleep, seizures)?
- What is the severity level, and what does that mean for support needs?
- What services and therapies do you recommend starting first?
- For adult diagnosis: Do you have experience diagnosing autism in adults?
Early Intervention & Therapies
Early intervention — ideally beginning before age 3 — is the most impactful action families can take. The brain is most adaptable in the first years of life, and evidence-based therapies during this window can produce lasting gains in communication, social skills, and adaptive functioning. Research shows IQ gains of 9–15 points and significant language improvements with intensive early intervention.
ABA is the most widely available and extensively researched intervention for autism. It uses principles of learning and motivation to teach new skills and reduce challenging behaviors. Modern ABA has evolved significantly from its earlier, more rigid forms.
- Evidence level: Strongest evidence base of any autism intervention. Hundreds of studies, multiple systematic reviews.
- How it works: A Board Certified Behavior Analyst (BCBA) designs an individualized program targeting specific goals. Registered Behavior Technicians (RBTs) deliver therapy, typically in the home or clinic.
- Intensity: Often recommended at 25–40 hours per week for young children, though evidence supports that quality matters more than raw hours.
- Key outcomes: Improvements in language, social skills, adaptive behavior, and reduction of challenging behaviors.
- Important nuance: Modern ABA emphasizes naturalistic teaching, child choice, and building on strengths. The autistic community has raised valid concerns about older, more compliance-focused ABA practices. Families should look for providers who use contemporary approaches, respect the child’s autonomy, and focus on functional skills rather than making the child “appear normal.”
NDBIs blend behavioral principles with developmental approaches, using the child’s natural interests and activities as the teaching context. These are sometimes called “next-generation” behavioral interventions.
- Early Start Denver Model (ESDM): For children 12–48 months. Combines ABA teaching strategies with relationship-based developmental approaches within play routines. Strong RCT evidence showing gains in IQ, language, and adaptive behavior. Typically 15–25 hours per week.
- JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation): Developed by Connie Kasari’s lab at UCLA. Focuses specifically on joint attention and play skills. Strong evidence from multiple randomized trials. Can be delivered by therapists or trained parents.
- Pivotal Response Treatment (PRT): Targets “pivotal” areas (motivation, self-initiation, responsivity to cues) to produce broad improvements. Child-directed, uses natural reinforcement.
- DIR/Floortime: Focuses on emotional development through following the child’s lead in play interactions. More limited research evidence than ABA or ESDM, but many families and clinicians report meaningful benefits.
Communication challenges are a core feature of autism, and speech-language therapy is one of the most commonly recommended services. Goals vary widely depending on the individual:
- Developing spoken language (for those with limited or no speech)
- Augmentative and Alternative Communication (AAC) systems — including picture exchange, speech-generating devices, and sign language
- Pragmatic (social) language skills — understanding conversational rules, reading social cues, interpreting figurative language
- Reducing echolalia or scripted language when it interferes with communication
- Feeding therapy for oral-motor or sensory-based eating difficulties
Key principle: Not speaking is not the same as not communicating. All individuals can communicate, and the goal is to find the most effective communication method for each person. AAC does not prevent speech development — research shows it often supports it.
Occupational therapy (OT) addresses the practical skills needed for daily living: fine motor skills, self-care (dressing, eating, hygiene), sensory processing, and participation in school and community activities.
Sensory processing differences are extremely common in autism — approximately 90% of autistic individuals experience some form of sensory sensitivity or seeking behavior. Common examples include:
- Hypersensitivity to sounds, lights, textures, or smells
- Sensory seeking (spinning, crashing, deep pressure)
- Difficulty with clothing textures, food textures, or grooming activities
- Challenges with motor planning and coordination
OT can help develop sensory strategies, create “sensory diets” (structured sensory activities throughout the day), and address fine motor and self-care skills. Sensory accommodations (noise-canceling headphones, fidget tools, weighted blankets) can significantly improve comfort and function.
- Ask about the evidence base: Is this therapy supported by peer-reviewed research?
- Ensure therapists are appropriately credentialed (BCBA for ABA, CCC-SLP for speech, OTR for OT)
- Look for individualized goals that are meaningful to your child and family
- The therapy should be respectful of the child’s autonomy and emotional well-being
- Progress should be measurable and regularly reviewed
- Parent training and involvement should be part of the program
- Avoid therapies that promise a “cure,” use aversive techniques, or lack published evidence
Accessing services can be confusing and emotionally draining. Here are practical steps:
- Contact your state early intervention program (Utah Baby Watch: 1-800-961-4226) to request an evaluation — you do not need a doctor’s referral.
- Get a comprehensive evaluation from a qualified diagnostician. Ask your pediatrician for referral to a developmental pediatrician or child psychologist.
- Understand your insurance coverage. Most states mandate autism coverage. Utah requires commercial insurers to cover ABA therapy. Medicaid also covers autism services.
- Start multiple services simultaneously if recommended — ABA, speech, and OT can all be done at the same time.
- Document everything. Keep copies of evaluations, therapy reports, IEPs, and correspondence with schools and providers.
- Take care of yourself. Caregiver burnout is real. Seek support from other families, respite care, and your own mental health providers if needed.
Families are often told a young child needs 25–40 hours a week of ABA, and it helps to understand both where that number comes from and how to weigh it. The intensive-hours recommendation traces to early studies of comprehensive programs, but more recent understanding emphasizes that quality matters more than raw hours — a well-run, individualized, respectful program at moderate intensity can outperform a high-hour program that is poorly implemented or that exhausts the child. A few principles help you find the right level for your child. First, a child is a child first: therapy should not crowd out play, family time, rest, and ordinary childhood, and signs of stress, exhaustion, or distress are reasons to reassess intensity, not to push through. Second, the naturalistic developmental approaches (ESDM, JASPER, PRT) and parent-coaching models can deliver much of the benefit woven into everyday routines rather than as separate clinical hours. Third, the right number is the one that produces meaningful progress on goals you care about while your child remains engaged and reasonably happy — and it is entirely appropriate to ask a provider to justify their recommended hours and to adjust them based on how your child responds. More is not automatically better; well-matched is better.
One of the most important distinctions for families to learn is the difference between a tantrum and a meltdown, because they look similar but call for opposite responses. A tantrum is goal-directed — a child wants something, is partly in control, and watches for your reaction; it tends to stop when the goal is met or consistently not met. A meltdown is not manipulation and not a choice: it is an involuntary response to being overwhelmed — by sensory overload, accumulated stress, an unexpected change, or demands that exceeded capacity — in which the thinking, problem-solving part of the brain has effectively gone offline. Trying to reason, bargain, discipline, or add more input during a meltdown makes it worse. What helps is reducing demands and sensory input, ensuring safety, staying calm and quiet, and giving time and space to recover; explanations and problem-solving come later, once the child is regulated. Just as useful is prevention: noticing the early warning signs and the common triggers (hunger, tiredness, sensory environments, transitions, social demands) and heading them off, and recognizing that a meltdown is a sign your child was overwhelmed, not "naughty." Reframing meltdowns this way reduces everyone's distress and leads to responses that actually shorten them.
- Which therapies do you recommend starting first, and why?
- How many hours per week of each therapy are recommended?
- How will we measure progress, and how often will goals be reviewed?
- Should we pursue genetic testing?
- Are there waitlists for services? What can we do in the meantime?
- What parent training programs are available?
- How do we access early intervention (Part C) or preschool special education (Part B)?
- Should my child be evaluated for co-occurring conditions (ADHD, anxiety, sleep problems)?
School-Age Support & Education
School is where autistic children spend most of their waking hours, and getting the right educational supports in place is often the most practically impactful thing families can do. Federal law guarantees significant rights for students with disabilities, but families often need to actively advocate to ensure these are implemented effectively.
The Individuals with Disabilities Education Act (IDEA) is a federal law guaranteeing a Free Appropriate Public Education (FAPE) for children with disabilities from birth through age 21. For school-age children, this is implemented through an Individualized Education Program (IEP).
The IEP is a legal document developed by a team that includes parents, teachers, specialists, and an administrator. It contains:
- Present levels: The child’s current academic and functional performance
- Annual goals: Measurable objectives the child is expected to achieve
- Specialized instruction and related services: Speech therapy, OT, behavioral support, social skills training, etc.
- Accommodations and modifications: Changes to the environment, instruction, or assessment to support the child’s learning
- Placement: The least restrictive environment (LRE) where the child can receive FAPE
- Transition planning: Beginning at age 14–16 (varies by state), plans for post-secondary education, employment, and independent living
You are an equal member of the IEP team. You have the right to participate in all meetings, request evaluations, disagree with proposals, and access dispute resolution mechanisms (mediation, due process hearing) if you cannot reach agreement.
Section 504 of the Rehabilitation Act provides accommodations for students with disabilities who may not qualify for an IEP but still need support to access education. A 504 plan is less comprehensive than an IEP but still legally enforceable.
Common 504 accommodations for autistic students:
- Extended time on tests and assignments
- Preferential seating (away from distractions, near the teacher)
- Sensory breaks or access to a quiet space
- Visual schedules and advance notice of transitions
- Modified homework expectations
- Permission to use noise-canceling headphones or fidget tools
- Social skills support or a peer buddy system
- Transitions: Use visual schedules, timers, and advance warnings. Practice transitions during calm times.
- Sensory overload: Advocate for a quiet space the child can use when overwhelmed. Noise-canceling headphones, sunglasses, or designated sensory breaks.
- Social difficulties: Structured recess activities, peer mentoring programs, explicit social skills instruction. Lunch groups with a trusted adult.
- Bullying: Autistic children are at significantly higher risk of bullying. Schools must have anti-bullying policies. Document incidents and request written responses from administration.
- Executive function: Organizational support, checklists, assignment notebooks, broken-down tasks, and visual instructions.
- Behavioral challenges: Functional Behavior Assessment (FBA) followed by a Behavior Intervention Plan (BIP) as part of the IEP. Focus on understanding the function of behavior, not just suppressing it.
Practical tips for effective school advocacy:
- Put all requests in writing (email creates a paper trail)
- Bring a support person to IEP meetings (advocate, knowledgeable friend, partner)
- Request an independent educational evaluation (IEE) if you disagree with the school’s evaluation
- Contact the Utah Parent Center (1-800-468-1160) for free advocacy support and training
- Know that you can record IEP meetings (with notice in most states)
- Visit the classroom to understand the environment
- Build relationships with teachers and staff — they are your partners
- If needed, file a complaint with the Utah State Board of Education or request mediation/due process
An IEP meeting can feel intimidating — you sit across from a table of professionals discussing your child — but a little preparation shifts the balance and reminds everyone that you are an equal, legally recognized member of the team. Before the meeting: review the current IEP and progress reports, write down your child's strengths and your top two or three priorities, and gather any outside evaluations or therapy reports that support what you are asking for. Put significant requests in writing (email) ahead of time so they are on the record. Consider bringing a support person — a partner, a knowledgeable friend, or a trained advocate (in Utah, the free Utah Parent Center can help) — and know that in most states you may record the meeting with notice. During the meeting: ask for plain-language explanations of anything unclear, focus on specific, measurable goals and the supports needed to reach them, and frame requests around your child's needs and the law's promise of a "free appropriate public education in the least restrictive environment." You do not have to agree or sign on the spot; you can take the document home to review, request changes, and ask for another meeting. If you disagree with an evaluation you can request an independent one, and formal options (mediation, due process) exist if agreement cannot be reached. Above all, you and the school staff are partners working toward the same goal — approaching the meeting collaboratively while knowing your rights tends to produce the best plan.
- What is the least restrictive environment for my child?
- How will sensory needs be accommodated in the classroom?
- What social skills support is available?
- How do you handle behavioral challenges? Is there a behavior plan?
- What training have staff received about autism?
- How will progress toward IEP goals be measured and reported?
- What is the plan for transitions (between classes, to a new school, to secondary school)?
- When will transition planning for adulthood begin?
Medications & Co-occurring Conditions
There is no medication that treats the core features of autism. However, co-occurring conditions — irritability, ADHD, anxiety, insomnia, seizures, and depression — are extremely common in autistic individuals and can significantly impair quality of life. Medication, when carefully chosen and monitored, can meaningfully improve functioning and well-being.
Only two medications are FDA-approved specifically for irritability associated with ASD:
- Risperidone (Risperdal): FDA-approved for irritability in ASD for ages 5–16. Can reduce aggression, self-injury, and severe tantrums. Side effects include weight gain, metabolic changes, sedation, and movement disorders. Requires metabolic monitoring.
- Aripiprazole (Abilify): FDA-approved for irritability in ASD for ages 6–17. Similar efficacy to risperidone with a potentially more favorable metabolic profile, though weight gain still occurs. Side effects include sedation, nausea, and movement disorders.
Before starting medication for irritability: Always conduct a thorough search for underlying causes. Pain (dental, ear infections, GI issues), sleep deprivation, environmental stressors, untreated medical conditions, and communication frustration can all drive challenging behaviors. A Functional Behavior Assessment (FBA) should be completed to understand the behavior’s function.
ADHD co-occurs in 50–70% of autistic individuals. Since 2013, the DSM-5 allows dual diagnosis of ASD and ADHD. Treatment options include:
- Stimulant medications (methylphenidate, amphetamines): Can be effective but may have a lower response rate in autistic individuals compared to neurotypical children with ADHD (approximately 50% vs. 70–80%). More likely to cause side effects including irritability, mood changes, and appetite suppression.
- Non-stimulant medications: Guanfacine (Intuniv) and clonidine (Kapvay) may be preferred for some autistic individuals due to their calming effects and evidence supporting their use in ASD-ADHD. Atomoxetine (Strattera) is another option. Recent evidence suggests alpha-2 adrenergic agonists (guanfacine, clonidine) may be preferred over stimulants as first-line for some autistic children with ADHD.
Start low, go slow. Autistic individuals are often more sensitive to medication effects and side effects. Begin with lower doses than standard ADHD guidelines recommend and titrate gradually.
Anxiety affects 40–50% of autistic individuals, and depression is increasingly recognized, especially in adolescents and adults. Treatment approaches:
- CBT (Cognitive Behavioral Therapy): Modified CBT protocols for autistic individuals show moderate evidence. Modifications include more visual supports, concrete examples, and less reliance on abstract cognitive concepts.
- SSRIs (fluoxetine, sertraline, escitalopram): Commonly prescribed for anxiety and depression. Evidence in autistic populations is more limited than in the general population. May be more likely to cause activation (restlessness, agitation) in autistic individuals. Some emerging research suggests buspirone or mirtazapine may be preferable for anxiety in ASD.
- Environmental modifications: Reducing demands, increasing predictability, providing sensory accommodations, and addressing communication barriers can significantly reduce anxiety.
Sleep difficulties affect 50–80% of autistic individuals. Poor sleep worsens virtually every other challenge. Treatment approaches:
- Sleep hygiene and behavioral strategies (first-line): Consistent bedtime routine, visual sleep schedule, dark and quiet sleep environment, limiting screens before bed, reducing stimulation in the evening.
- Melatonin: The most commonly used supplement for sleep in autism. Good evidence supporting its use for sleep-onset difficulty. Typical doses: 1–5 mg, given 30–60 minutes before desired bedtime. Generally safe with few side effects. Extended-release formulations can help with night wakings.
- Prescription options: Clonidine is sometimes used for both sleep and ADHD symptoms. Low-dose trazodone or gabapentin may be considered for persistent insomnia.
Epilepsy affects 20–30% of autistic individuals, with two peak onset periods: early childhood and adolescence. Any autistic individual with staring spells, unusual movements, or regression should be evaluated with an EEG.
Antiseizure medications (levetiracetam, valproate, lamotrigine, and others) are chosen based on seizure type. Valproate should be avoided in women of childbearing potential due to teratogenicity.
Some widely marketed treatments have no evidence of benefit and may cause harm:
- Chelation therapy: No evidence of benefit; can cause serious harm including kidney failure and death. The premise that heavy metals cause autism is not supported by evidence.
- Hyperbaric oxygen therapy: No convincing evidence for autism. Expensive and time-consuming.
- Secretin infusions: Multiple controlled trials showed no benefit.
- MMS (Miracle Mineral Solution / chlorine dioxide): Essentially industrial bleach. Dangerous. Has caused serious injuries.
- Stem cell therapy (unregulated clinics): No proven benefit for autism. Risk of serious adverse events from unlicensed providers.
- Restrictive diets without medical indication: Gluten-free/casein-free diets are not supported by high-quality evidence for autism. Restrictive diets in children who already have limited food preferences can lead to nutritional deficiencies.
Always discuss any treatment — conventional or alternative — with your medical team before starting.
Deciding whether to start a medication can feel fraught, and a clear framework eases it. Start from the principle that medication in autism treats a specific co-occurring problem — severe irritability that endangers your child or others, ADHD that makes learning impossible, anxiety or depression that causes real suffering, insomnia that wrecks the whole family's functioning, or seizures — never "the autism" itself. So the first question is: what specific symptom are we targeting, and how much is it actually harming quality of life or safety? The second is whether behavioral and environmental approaches have been genuinely tried, since they should usually come first or alongside — and whether a treatable physical cause (pain, constipation, poor sleep) has been ruled out, because medicating a hidden source of distress is a common mistake. If a medication is reasonable, useful questions are: what is the expected benefit and the realistic timeline, what side effects should we watch for (and what monitoring, such as the metabolic checks needed with risperidone and aripiprazole), is this use FDA-approved or off-label, and what is the plan if it does not help. Because autistic individuals are often more sensitive to both effects and side effects, expect a "start low, go slow" approach and one change at a time. Finally, a medication trial is not a permanent commitment: it is a carefully monitored experiment that can be stopped or adjusted, and the decision is always yours to make with a clinician you trust.
- What co-occurring condition are we treating with this medication?
- What behavioral and environmental interventions should we try first or alongside medication?
- What are the expected benefits, and how long until we see them?
- What side effects should I watch for? What requires an immediate call?
- How will we monitor for metabolic side effects (weight, blood sugar, lipids)?
- Is this medication FDA-approved for this use, or is it off-label?
- What happens if this medication doesn’t work? What’s the next option?
- Should we do an EEG to check for seizure activity?
- Could any of the current behaviors be caused by pain or a medical condition?
Prenatal Factors, Pregnancy & Special Populations
Autism is strongly heritable, and in most children no single cause can be identified. A number of prenatal and perinatal factors are associated with a modestly increased likelihood of autism — but “associated with” is not the same as “causes,” and the large majority of children exposed to these factors are not autistic. This section also covers considerations for autistic adults during pregnancy and for groups whose autism is often missed.
- Valproate and some anti-seizure medications: Taking valproate (Depakote/sodium valproate) during pregnancy is the most clearly established medication-related risk factor, associated with a higher rate of autism and other neurodevelopmental effects in the child. For this reason valproate is generally avoided in people who are or could become pregnant when effective alternatives exist. Never stop a seizure or psychiatric medication on your own — uncontrolled seizures are also dangerous. Discuss alternatives with your neurologist before pregnancy where possible.
- Parental age: Advanced maternal and paternal age are associated with a small increase in likelihood.
- Pregnancy & birth complications: Significant prematurity, very low birth weight, and some maternal infections or prolonged high fevers during pregnancy are associated with modestly higher likelihood.
- Folic acid is protective: Adequate folate (folic acid) before conception and in early pregnancy is associated with a lower rate of autism — one more reason for standard prenatal folic-acid supplementation.
- Vaccines do not cause autism. This has been studied in millions of children worldwide. The original claim came from a small, fraudulent study that was retracted, and its author lost his medical license. Following the routine vaccine schedule — including MMR — does not cause autism, and skipping vaccines exposes children to serious preventable diseases.
- Autistic adults can and do become parents. Pregnancy care can be adapted — for example, requesting clear written information, predictable appointments, accommodations for sensory sensitivities during exams, and a quiet space during labor.
- Medication during pregnancy: If you take medication for co-occurring anxiety, depression, ADHD, or epilepsy, do not stop abruptly. Work with your prescriber and an obstetric specialist to weigh the risks of the medication against the risks of an untreated condition. Valproate in particular should be reviewed and usually changed before pregnancy.
- Tell your maternity team what supports help you. You are entitled to reasonable accommodations.
- Girls and women: Autism is under-recognized in girls and women, who are more likely to “camouflage” (mask) their difficulties and may be diagnosed later or misdiagnosed with anxiety or depression first. A girl who is quiet and rule-following can still be autistic.
- Adults diagnosed later in life: Many autistic adults were never identified as children. Seeking a diagnosis as an adult is valid and can bring access to support, self-understanding, and workplace accommodations.
- People with high support needs / minimally speaking individuals: Communication differences should never be mistaken for an absence of understanding. Augmentative and alternative communication (AAC) tools and presumed competence are essential.
- Co-occurring intellectual disability and genetic conditions: Some autistic people also have intellectual disability or an identifiable genetic syndrome (e.g., Fragile X, tuberous sclerosis, Rett syndrome). Genetic evaluation can sometimes clarify the picture and guide health monitoring.
- Diagnostic disparities: Children from Black, Hispanic, and lower-income families, and those in rural areas, are often diagnosed later. If you have concerns, you can request an evaluation regardless of these barriers — ask for it in writing.
- I take [medication] and am pregnant or planning to be — is it safe to continue, and are there safer alternatives I should switch to first?
- I’m on valproate — should I change medication before trying to conceive?
- I think I (or my daughter) may be autistic even though we don’t fit the usual picture — can we still be evaluated?
- Would a genetic evaluation be useful in our situation?
Adolescence, Transition & Adult Life
Autism is a lifelong condition, and the transition from childhood through adolescence to adulthood involves significant changes in services, supports, and challenges. Planning for this transition should begin years before the actual shift occurs — ideally by age 14–16.
Adolescence can be particularly challenging for autistic individuals:
- Social complexity increases dramatically — friendships become more nuanced, peer pressure intensifies, and social rules become harder to navigate
- Mental health risks rise — anxiety, depression, and suicidal ideation increase during adolescence, and autistic teens are at elevated risk
- Puberty and sexuality — may need explicit instruction about body changes, personal hygiene, boundaries, consent, and healthy relationships
- Identity development — many autistic adolescents become more aware of their differences and may benefit from connection with autistic peers and the neurodiversity community
- Seizure risk increases — adolescence is a second peak period for seizure onset in autism
- Academic demands increase — less structured time, more executive function demands, and increased emphasis on independent work
Under IDEA, transition planning must begin by age 16 (some states require age 14). This is a formal process within the IEP that addresses:
- Post-secondary education: College disability services, vocational training programs, certificate programs. Many universities have specialized autism support programs.
- Employment: Vocational rehabilitation services, supported employment programs, job coaching. The Utah Division of Services for People with Disabilities can provide vocational support.
- Independent living: Daily living skills training, housing options (independent, supported, group homes), transportation.
- Healthcare transition: Moving from pediatric to adult healthcare providers. Establishing care with adult-friendly providers who understand autism.
- Legal/financial planning: Guardianship vs. supported decision-making, ABLE accounts, special needs trusts, Social Security benefits (SSI/SSDI).
Many adults are discovering they are autistic for the first time. Late diagnosis can be profoundly validating, providing an explanation for lifelong experiences. Key areas for autistic adults:
- Employment: Autistic adults face high unemployment rates (estimated 50–75% under- or unemployed), but many thrive in the right environment. Accommodations like flexible schedules, clear expectations, reduced sensory distractions, and written (vs. verbal) instructions can make a significant difference.
- Relationships: Many autistic adults develop meaningful relationships. Explicit communication about needs, boundaries, and expectations is key. Couples counseling with a therapist who understands autism can be helpful.
- Autistic burnout: A state of chronic exhaustion, loss of function, and reduced tolerance for stimulation resulting from sustained masking and overwhelming demands. Requires rest, reduced demands, and sensory accommodations — not more therapy or medication.
- Mental health: Autistic adults are at increased risk for anxiety, depression, and suicidal ideation. Finding mental health providers who understand autism is essential.
- Community: Connection with other autistic adults — online communities, in-person groups, autistic-led organizations (ASAN, AANE) — can be transformative.
Puberty, sexuality, and relationships are too often left out of conversations about autistic teens, and that silence does real harm — autistic young people have the same developing bodies, feelings, and desire for connection as their peers, and they are also at elevated risk of exploitation and abuse, which makes proactive, explicit education protective rather than optional. A few principles guide this. Teach concretely and early: the body changes of puberty, hygiene routines, and the social rules around privacy and personal space frequently need to be taught explicitly and stepwise rather than assumed to be absorbed, and visual supports and clear language help. Cover boundaries, consent, and safety directly: which body parts are private, what kinds of touch are and are not okay, that no one should ask them to keep secrets about touch, and how to tell a trusted adult — this education measurably reduces vulnerability to abuse, to which autistic individuals are disproportionately exposed. Support healthy relationships and intimacy as your teen matures, with explicit conversations about communication, consent, and expectations, and access to autism-informed guidance when wanted. Online safety deserves specific attention, since social media and messaging can be both a valuable avenue for connection and a source of risk. None of this needs to happen in one conversation; it unfolds over years, matched to your teen's development. Connecting them with autistic peers and the autistic adult community also provides models and a sense that relationships and a full adult life are realistic.
When an autistic individual turns 18, they are legally an adult with full decision-making rights, regardless of support needs. Options for families include:
- Full guardianship: A court transfers all decision-making authority to a guardian. This is the most restrictive option and should be considered only when less restrictive alternatives are insufficient.
- Limited guardianship: A guardian makes decisions only in specific areas (medical, financial) while the individual retains autonomy in others.
- Supported decision-making: A less restrictive alternative where trusted people help the individual understand and make decisions without removing their legal rights. Increasingly recommended.
- Powers of attorney and healthcare directives: The individual can voluntarily designate someone to make specific decisions on their behalf.
Consult with a disability rights attorney to determine the most appropriate and least restrictive option.
The years before adulthood are the time to deliberately grow the skills and self-knowledge that adult life will require — and to start handing over the controls, gradually and with support, rather than all at once at eighteen. Independence is built skill by skill: cooking a few meals, managing money, using transportation, doing laundry, scheduling and attending appointments, and managing medications can be taught and practiced for real over years, not lectured about once. Equally important is self-advocacy — helping your teen understand their own autism in a positive frame, know what supports and accommodations help them, and learn to ask for those things at school, at work, and in healthcare. This includes bringing them into their own IEP and medical conversations as they grow, so that by adulthood they can speak for themselves rather than have others speak for them. Two adjustments make this work for autistic teens specifically: teach skills explicitly and concretely (checklists, step-by-step routines, role-play) rather than expecting them to be absorbed implicitly, and accept that independence may look different than for peers — partial independence with the right supports is a genuine success, not a consolation prize. Connecting your teen with autistic adults and the autistic community can be transformative here, offering role models and a sense that an autistic adulthood can be a good one. The goal is not to make your teen "less autistic" but to equip them to run their own life, on their own terms, with whatever scaffolding fits.
- Who will manage my/my child’s healthcare after the transition from pediatric care?
- What vocational rehabilitation services are available?
- Should we apply for SSI or SSDI? When should we start?
- What housing options are available for adults with autism in our area?
- Do we need guardianship, or would supported decision-making be appropriate?
- What community resources exist for autistic adults?
- How can we plan financially for long-term support needs (ABLE account, special needs trust)?
Living Well & Family Support
While autism presents real challenges, many autistic individuals live fulfilling, meaningful lives — and families can thrive too. This section addresses the practical and emotional aspects of daily life.
- Visual supports: Visual schedules, social stories, and visual checklists help with predictability and independence. These work for all ages, not just young children.
- Routine and structure: Most autistic individuals benefit from predictable routines. Provide advance notice of changes whenever possible.
- Sensory environment: Create sensory-friendly spaces at home. Consider lighting, noise levels, textures, and smells. Designate a calm-down space for overwhelming moments.
- Communication tools: Use the communication method that works best — speech, AAC, picture exchange, text/email. Many autistic individuals communicate more effectively in writing than in speech.
- Exercise and physical activity: Regular physical activity improves behavior, mood, sleep, and overall health. Swimming, martial arts, hiking, and individual sports are often preferred over team sports.
- Nutrition: Many autistic individuals have restricted diets due to sensory sensitivities. Work with a feeding therapist if nutritional concerns exist. Avoid forcing new foods — gradual, positive exposure is more effective.
Because sensory differences are nearly universal in autism, small changes to the home environment can meaningfully reduce daily distress and the meltdowns that overload produces. The aim is not a clinical environment but a home that is a little calmer and more predictable. Useful adjustments, tailored to your child's particular sensitivities, include: softening harsh lighting (warmer bulbs, dimmers, natural light, avoiding flickering fluorescents); reducing background noise (rugs and soft furnishings absorb sound, and noise-canceling headphones or quiet hours help); being mindful of strong smells (cleaning products, air fresheners, cooking odors); and offering comfortable clothing and bedding (tagless, soft fabrics, the right weight of blanket). Many families create a calm-down space — a corner, tent, or small room with low light, soft textures, and favorite comfort items — that the child can go to, or be guided to, when overwhelmed; framed as a safe retreat rather than a punishment, it becomes a powerful self-regulation tool. Some children are sensory seekers rather than avoiders and need the opposite: movement, deep pressure, a swing, a weighted blanket, or a "crash pad." An occupational therapist can help you read your child's specific sensory profile and build a "sensory diet" of activities that keep them regulated through the day. The goal is a home environment that works with your child's nervous system instead of constantly against it.
One principle reshapes how families support communication: not speaking is not the same as not communicating, and not communicating in the usual way is not the same as not understanding. Every autistic person communicates — through words, behavior, gestures, devices, writing, or a combination — and the task is to find and honor the methods that work for each individual rather than to insist on speech as the only valid output. For minimally speaking or non-speaking individuals, augmentative and alternative communication (AAC) — picture systems, speech-generating devices, typing, or sign — can be transformative, and an important, evidence-backed reassurance for worried parents is that AAC does not hold back speech; it often supports its development. Two further ideas matter. First, presume competence: assume the person understands more than they can express, speak to them at an age-appropriate level, and never discuss them as if they were not present — communication difference must never be mistaken for cognitive absence. Second, many autistic people communicate far more comfortably in writing or text than in face-to-face speech, and meeting them in their preferred medium often unlocks conversations that pressure for spoken answers shuts down. Behavior, too, is communication, especially distress behavior in someone who cannot easily put a feeling or a pain into words. Approaching your child as a communicator who is always trying to tell you something — and adapting to their channel rather than demanding they adapt to yours — is one of the most respectful and effective things a family can do.
Many autistic children eat a very limited range of foods, and it helps to understand that this is usually not stubbornness or ordinary picky eating but a real response to sensory experience — the texture, smell, temperature, look, or even the brand of a food can be genuinely intolerable, and the comfort of sameness is powerful. Pushing, pressuring, or forcing new foods reliably backfires, increasing anxiety around eating and shrinking the safe-food list further. More effective approaches are gentle and gradual: keep mealtimes low-pressure and positive, continue to offer new foods alongside accepted ones without demanding they be eaten, and allow exploration (touching, smelling, licking) as steps toward eventually tasting. Reducing sensory load at the table — calm environment, familiar plates, foods not touching if that matters to your child — can help, as can involving your child in shopping and simple cooking. When restriction is severe, though, it deserves medical attention rather than being waited out: very limited diets can cause real nutritional deficiencies and growth concerns, and a feeding therapist (often a speech or occupational therapist) plus a dietitian, with a check for any underlying constipation or reflux that makes eating uncomfortable, can make a meaningful difference. The goal is to gently widen variety and protect nutrition over time — not to win a battle at any single meal, which is a contest no one wins.
Difficulty with change and transitions is one of the most universal autistic experiences, and small everyday frictions — ending a preferred activity, leaving the house, a switch in plans — can trigger genuine distress because predictability is how many autistic people manage an overwhelming world. The good news is that this is one of the most improvable areas with simple tools. Visual schedules (pictures or words showing the sequence of the day) turn the invisible and uncertain into something concrete and reassuring, and they work for all ages, not just young children. Advance warning — "five more minutes, then we'll clean up," ideally paired with a visual timer — gives the brain time to shift gears rather than being yanked from one thing to another. Preparing for bigger changes ahead of time (a social story or simple explanation about a new school, a trip, a doctor's visit, or a change in routine) reduces the shock of the unexpected. Where you can, keep core routines stable and predictable, and when change is unavoidable, name it clearly and early rather than hoping it will go unnoticed. Over time, you can also gently build flexibility by practicing small, low-stakes changes during calm moments. Recognizing that resistance to change is anxiety rather than defiance shifts your response from frustration to support — and the right tools genuinely make daily life smoother for the whole family.
Siblings of autistic individuals often experience a mix of love, frustration, pride, and worry. They may feel overlooked or burdened with extra responsibilities. Strategies to support siblings:
- Dedicate regular one-on-one time with each sibling
- Explain autism in age-appropriate terms
- Validate their feelings — it is okay to feel frustrated, embarrassed, or sad sometimes
- Connect them with sibling support groups (the Sibling Support Project offers “Sibshops”)
- Avoid making them responsible for their sibling’s behavior or care
- Celebrate their own achievements and interests
Many autistic children want friendship deeply, even when their way of seeking it looks different, and a common misconception is that they prefer to be alone. Supporting connection works best when it plays to your child's nature rather than against it. Shared interests are the strongest bridge: friendships often form most easily around a common passion — a game, a hobby, animals, building things — so structured activities, clubs, and groups organized around an interest tend to work far better than unstructured "go play" situations that leave a child adrift. Structure and small numbers help: a planned activity with a clear purpose, one or two children rather than a crowd, and a familiar setting reduce the social load and make success more likely than a big, loud, open-ended gathering. Explicit teaching has a place too — many social skills that other children pick up implicitly can be taught directly and kindly (how to join a game, take turns in conversation, recognize when someone wants space) — but the goal is to help your child connect in ways that feel authentic, not to script them into masking who they are. Crucially, autistic-to-autistic friendships are often the easiest and most rewarding, because shared communication styles remove much of the friction; seek out autistic peers, groups, and (for teens and adults) the autistic community. And remember that one or two genuine friendships matter far more than popularity — quality, on your child's terms, is the goal, not a wide social circle that exhausts them.
Parents and caregivers of autistic individuals report higher rates of stress, depression, and burnout than parents of typically developing children or children with many other conditions. Taking care of yourself is not selfish — it is necessary.
- Respite care: Planned breaks from caregiving. Utah’s Division of Services for People with Disabilities offers respite care programs.
- Support groups: Connecting with other families who understand. In-person groups, online communities, and organizations like the Autism Society and CHADD provide connection.
- Your own mental health: Seek therapy, counseling, or medication for your own anxiety, depression, or stress. Many therapists specialize in supporting parents of children with disabilities.
- Relationship health: The stress of caregiving can strain partnerships. Prioritize communication and seek couples counseling if needed.
- Financial planning: Work with a financial advisor experienced in disability planning. Consider ABLE accounts (tax-advantaged savings that don’t affect benefits eligibility), special needs trusts, and life insurance planning.
Many parents wonder whether, when, and how to tell their child they are autistic. The growing consensus from autistic adults is clear: knowing tends to help, and learning it early and positively is far better than discovering it later by accident or inferring it from a sense of being "different and wrong." A child who understands they are autistic can make sense of their own experiences, ask for what they need, and build an identity that includes autism as a neutral-to-positive fact rather than a shameful secret. How you frame it matters enormously. Present autism as a different way of having a brain — with real strengths as well as real challenges — not as a disease or a defect. Tailor the conversation to your child's age and understanding, and expect it to be an unfolding series of conversations rather than a single "talk." Connect the explanation to their own lived experience ("this is why loud places feel so big to you, and why you're so amazing at remembering things about trains"). Avoid language that frames autism as something broken or to be hidden, since children absorb that framing into their self-image. Many families find it powerful to introduce autistic role models, books by autistic authors, and — as the child grows — connection with other autistic people, so that being autistic comes with a sense of belonging rather than isolation. The aim is for your child to grow up knowing they are a whole, capable person who happens to be autistic, understood and accepted by the people who love them most.
The neurodiversity perspective holds that autism and other neurological differences are natural variations of the human brain rather than deficits to be corrected. This does not mean that autistic individuals do not face real challenges or that support is unnecessary — it means that those challenges are addressed while respecting and valuing the person as they are.
Many autistic individuals describe unique strengths including deep focus and expertise in areas of interest, attention to detail, pattern recognition, honesty and directness, loyalty, and creative problem-solving. Supporting an autistic person means building on these strengths while addressing genuine difficulties.
The neurodiversity framework is compatible with seeking evidence-based support. The goal is not to make an autistic person “indistinguishable from peers” but to help them develop skills to navigate the world in ways that work for them, while the world also adapts to be more inclusive.
Autism support is often framed entirely around challenges, but some of the most powerful long-term gains come from leaning into strengths — and special interests are frequently the single most underused asset in an autistic person's life. The intense, focused interests that are sometimes treated as a problem to limit are, handled well, a source of joy, motivation, expertise, social connection, and even careers. Rather than restricting an interest, you can build through it: a child fascinated by trains can practice reading, math, conversation, and turn-taking through trains; an interest in animals, computers, music, art, or a particular game can become the bridge to learning, friendship with others who share it, and eventually meaningful work. Many autistic adults trace their careers and their closest friendships directly to a childhood "obsession." More broadly, autistic strengths — deep focus, attention to detail, pattern recognition, honesty, reliability, strong memory, novel problem-solving, and a powerful sense of fairness — are real and valuable, and a child who grows up hearing about their strengths as well as their struggles develops a healthier self-concept. This does not mean ignoring genuine difficulties; it means addressing them while making sure your child knows they are a whole, capable person with gifts, not a list of deficits. Ask regularly: what is going well, what does my child love, and how can we build a life around their strengths rather than only managing their challenges?
While autism is a lifelong neurodevelopmental condition, early evidence-based intervention, appropriate support, and individualized planning can lead to meaningful progress and fulfilling lives across the spectrum. Many autistic individuals thrive with the right supports in place.
The landscape of autism understanding and support has transformed in recent decades. More services are available, more adults are being diagnosed and finding community, research continues to advance, and society is slowly becoming more inclusive. Whatever stage you are at in this journey, there are people and resources ready to help.
Support & Resources
| Resource | Description | Contact |
|---|---|---|
| University of Utah Neurobehavior HOME Program | Comprehensive autism evaluation and management for children and adults. Multidisciplinary team. | 240 E Morris Ave, 4th Floor, Salt Lake City, UT 84115 · 801-587-8020 |
| Carmen B. Pingree Autism Center of Learning | Intensive ABA-based learning and therapy programs for young children with autism (Valley Behavioral Health). | 780 S Guardsman Way, Salt Lake City, UT 84108 · 801-581-0194 |
| USU ASSERT (Utah State University, Logan) | Early-intervention preschool, parent training, and autism research/training through Utah State University. | Sorenson Center for Clinical Excellence, USU · assert@usu.edu |
| Utah Baby Watch / Early Intervention | Free evaluation and early intervention services for children birth to age 3 with developmental concerns. | 1-800-961-4226 · health.utah.gov/cshcn |
| Utah Parent Center | Free training, information, and advocacy support for families of children with disabilities. IEP assistance. | 1-800-468-1160 · utahparentcenter.org |
| Utah Autism Council | Statewide council connecting families to resources, training, and community events. | utahautismcouncil.org |
| Utah State Board of Education — Special Education | Oversees special education in Utah public schools. Procedural safeguards, dispute resolution. | schools.utah.gov/specialeducation · 801-538-7500 |
| Utah Division of Services for People with Disabilities (DSPD) | Medicaid waiver programs, residential services, employment support, and respite care for individuals with disabilities. | dspd.utah.gov · 1-877-568-1150 |
| Utah Medicaid Waiver Programs | Community Supports Waiver, Medically Complex waiver, and other programs providing home and community-based services. | Contact DSPD for waiver information |
| Organization | Focus | Website |
|---|---|---|
| Autism Society of America | Oldest autism organization in the US. Education, advocacy, community support. Local affiliates. | autismsociety.org |
| Autistic Self Advocacy Network (ASAN) | Autistic-led organization promoting neurodiversity, civil rights, and systems change. | autisticadvocacy.org |
| AANE (Association for Autism and Neurodiversity) | Support for autistic individuals, particularly adults and those diagnosed later in life. | aane.org |
| Autism Speaks | Research funding, advocacy, resource guides. Note: some autistic-led organizations have expressed concerns about this organization’s approach. | autismspeaks.org |
| CHADD (Children and Adults with ADHD) | Relevant for the 50–70% of autistic individuals who also have ADHD. | chadd.org |
| The Arc | Advocacy for people with intellectual and developmental disabilities. Local chapters throughout Utah. | thearc.org |
- 988 Suicide and Crisis Lifeline: Call or text 988 (24/7). For autistic individuals experiencing mental health crisis.
- Crisis Text Line: Text HOME to 741741.
- University Neuropsychiatric Institute (UNI): Psychiatric crisis services in Salt Lake City. 801-583-2500.
- SafeUT app: Free crisis intervention for Utah youth. Available on iOS and Android.
- Utah Mobile Crisis Outreach Teams (MCOT): In-person crisis support. Available in some Utah counties.
- ABLE accounts: Tax-advantaged savings accounts for individuals with disabilities. Funds do not affect SSI or Medicaid eligibility (up to limits). Available through the ABLE National Resource Center (ablenrc.org).
- SSI (Supplemental Security Income): Federal income support for individuals with disabilities who have limited income and resources. Apply through the Social Security Administration (ssa.gov). As of 2026, the Payroll Information Exchange (PIE) simplifies documentation of employment income for beneficiaries.
- Special needs trusts: Legal trusts that hold assets for a person with a disability without affecting benefits eligibility. Consult a disability rights attorney.
- Disability Rights Utah: Free legal advocacy for people with disabilities in Utah. disabilityrightsutah.org · 1-800-662-9080.
Because there is no medication for the core features of autism and the diagnostic and service systems move slowly, families are a prime target for marketed "cures" and unproven treatments — some merely expensive and useless, others genuinely dangerous. A few questions protect you. Does it promise a cure? Autism is not a disease with a cure, so any product or program claiming to cure, reverse, or "recover" a child from autism is a red flag. Where is the evidence? Look for support from peer-reviewed research and reputable bodies, not testimonials, a single dramatic story, or a sales page — many things that seemed promising failed when properly tested. Does it tell you to stop standard care? A legitimate approach complements proven supports; one that demands you abandon them is dangerous. Who profits, and what's the risk? Be especially wary of anything injected, infused, or ingested at an out-of-network clinic, of chelation, of unregulated "stem cell" treatments, of hyperbaric oxygen marketed for autism, and above all of chlorine-dioxide "MMS," which is industrial bleach and has caused serious injuries. The most useful habit is simply to run anything you are considering — conventional or alternative — past your medical team and ask, "Is there real evidence for this, and is it safe?" Reputable, vetted information is available through the Association for Science in Autism Treatment (asatonline.org). Spending your energy, money, and hope on proven supports — rather than on the next miracle claim — is itself one of the best things you can do for your child.
Several areas of active research may expand treatment options in the future:
- Digital therapeutics and telehealth: Parent-mediated interventions delivered via telehealth showed promise during and after the COVID-19 pandemic. Digital tools for social skills training and behavior management are in development.
- Precision medicine: Using genetic and biomarker profiles to match individuals with the most effective interventions.
- Microbiome research: Growing evidence links gut microbiome differences to GI symptoms and potentially some behavioral features in autism. Clinical trials of microbiome-targeted therapies are ongoing, but this is not yet ready for clinical use.
- Virtual reality (VR) social skills training: Controlled environments for practicing social interactions. Early-stage research shows promise.
- Oxytocin and vasopressin research: Some trials have explored intranasal oxytocin for social cognition in autism. Results have been mixed, and this is not recommended as a treatment outside of clinical trials.
Important: Emerging research means the evidence is not yet sufficient for clinical recommendation. Discuss any interest in experimental treatments with your medical team.
Autism is recognized worldwide, but diagnostic practices, services, and prevalence estimates vary significantly:
- United Kingdom: NICE guidelines (CG128, CG170, CG142) provide comprehensive frameworks for diagnosis and management. The NHS offers diagnostic services through community teams, though wait times are often long.
- Europe: Prevalence estimates vary widely (0.6–1.2%) depending on diagnostic criteria and surveillance methods. The EU emphasizes inclusive education and community integration.
- Japan: Autism awareness has grown significantly. Some cultural differences affect presentation and service-seeking behavior. The term “developmental disorder” is commonly used.
- Australia: The National Disability Insurance Scheme (NDIS) provides funded therapy and support services for autistic individuals.
- Diagnostic classification: The US uses the DSM-5-TR while many other countries use the ICD-11, which has a similar but not identical approach to diagnosing autism.
- CDC ADDM Network — Autism Prevalence Data (2022 surveillance, published 2025)
- American Academy of Pediatrics (AAP) Clinical Report on ASD (2020)
- American Academy of Neurology (AAN) Practice Parameters for ASD
- NICE Guidelines CG128 (Recognition, Referral, Diagnosis), CG170 (Management in Under 19s), CG142 (Adults)
- AACAP Practice Parameters for ASD Assessment and Treatment
- Dawson et al. (2010) — Randomized controlled trial of the Early Start Denver Model
- Kasari et al. — JASPER intervention studies
- Research Units on Pediatric Psychopharmacology (RUPP) Autism Network — Risperidone and aripiprazole trials
- Schaefer et al. (2013) — Clinical genetics evaluation in ASD
- Autism CARES Act (Collaboration, Accountability, Research, Education, and Support)
Clinical Trials
Clinical trials are research studies that test new therapies, interventions, and assessment tools for autism spectrum disorder. Participating in a trial can provide access to promising new approaches while contributing to knowledge that benefits future generations. Clinical trials are not a last resort — they represent some of the most carefully monitored care available.
The following are real clinical trials registered on ClinicalTrials.gov. Availability, enrollment status, and eligibility criteria change frequently — always verify current status before pursuing enrollment.
- Balovaptan for social communication in ASD (Roche) — NCT03504917. A vasopressin V1a receptor antagonist tested in adults with ASD to improve social communication. The Phase III V1aduct trial did not meet its primary endpoint and was terminated; the separate pediatric trial (aV1ation) also failed, and Roche discontinued development for this indication.
- Bumetanide for core ASD symptoms — NCT03715153. Testing whether bumetanide (a diuretic that modulates GABA signaling) improves social communication in children with ASD. Phase III trials in Europe did not meet primary endpoints; further investigation is ongoing in selected populations.
- CM-AT (pancreatic enzyme-based therapy) — NCT02410902. A pancreatic enzyme formulation tested for social withdrawal and other core ASD features in children ages 3–8. The Phase III “Blum Study” (Curemark) has completed; it has not led to FDA approval, and CM-AT is not available as an approved treatment.
- Suramin low-dose infusion — NCT02508259. An antipurinergic drug being studied in a small controlled trial at UC San Diego for core ASD features. A small Phase I/II study showed preliminary signals; larger trials are needed.
- Microbiota Transfer Therapy (MTT) — NCT03408886. Fecal microbiota transplantation being studied at Arizona State University for GI symptoms and behavioral outcomes in autistic children and adults. Open-label extension studies have reported sustained improvements in GI and behavioral measures, but controlled data remain limited.
- ESDM in community settings — the Early Start Denver Model is an established, evidence-based early-intervention approach; community-implementation effectiveness studies (delivering it through community early-intervention programs rather than university clinics) are ongoing. Search ClinicalTrials.gov for currently recruiting sites.
- Oxytocin for social cognition in ASD — NCT01944046. Multiple trials have tested intranasal oxytocin. The large SOARS-B study (Duke/UNC-led ACE network) found no significant benefit on primary social outcomes. Oxytocin is not recommended for ASD outside of clinical trials.
- Cannabidiol (CBD) in ASD — NCT03900923. An open-label Phase 2 study of pharmaceutical-grade CBD looking at social competence and anxiety. Results are preliminary, and over-the-counter CBD products are not equivalent to pharmaceutical formulations and are not recommended.
- Ask your medical team first. Your child’s developmental pediatrician, psychiatrist, or neurologist may know of open trials at your center or nearby academic institutions.
- Search ClinicalTrials.gov — the official U.S. registry. Filter by condition (“autism spectrum disorder”), age, recruiting status, and location.
- Contact an autism research center. Major academic centers with active ASD trial programs include the Marcus Autism Center (Emory), UCLA Semel Institute, UC Davis MIND Institute, Yale Child Study Center, and Kennedy Krieger Institute.
- Autism research networks: The Autism Biomarkers Consortium for Clinical Trials (ABC-CT), the SPARK study (simonsfoundation.org/spark), and the Autism Speaks Clinical Trials Network can connect families with open studies.
- For adults: Adult ASD trials are increasing but still relatively uncommon. Academic medical centers with dedicated adult autism programs are the best starting point.
- All clinical trials must be approved by an Institutional Review Board (IRB) that ensures participant safety.
- Participants (or their legal guardians) must provide informed consent. You can withdraw at any time without affecting your regular care.
- Some trials use a placebo (inactive treatment). Ask whether you will know which group you are in and whether the active treatment will be offered afterward.
- Trial participation often includes more frequent and detailed monitoring than standard care.
- Many trials cover the cost of the experimental treatment and study-related procedures. Ask about costs, time commitment, and travel before enrolling.
⚠ Safety — Treatments to Be Wary Of
Some products and interventions marketed for autism have no scientific evidence of benefit and carry serious risks. Be extremely cautious of the following:
- Chelation therapy: Based on the disproven theory that heavy metals cause autism. There is no evidence it helps, and it carries risk of serious harm including kidney failure, cardiac arrest, and death. The FDA has warned against chelation products marketed for autism.
- MMS / chlorine dioxide / “Miracle Mineral Supplement”: This is industrial bleach. It causes severe chemical burns to the mouth, throat, and gastrointestinal tract. The FDA has issued multiple warnings. People have been prosecuted for selling it as an autism treatment.
- Hyperbaric oxygen therapy (HBOT): No credible evidence supports its use for autism spectrum disorder. It is expensive, time-consuming, and not covered by insurance for this indication. Carries risks including ear injuries and, rarely, oxygen toxicity.
- Stem-cell tourism: Unregulated clinics abroad offer unproven stem-cell injections marketed as autism treatments. There is no proven benefit. Risks include infection, immune reactions, tumor formation, and death. Legitimate stem-cell research for autism is in very early stages and available only through regulated clinical trials.
- Restrictive diets as “cures”: Gluten-free/casein-free (GF/CF) diets are sometimes promoted as autism treatments. While dietary changes may help some individuals with specific GI symptoms, there is no high-quality evidence that these diets treat core autism features. Severely restrictive diets in children — especially those who already have limited food preferences — carry a real risk of malnutrition and growth problems.
Any product or practitioner claiming to “cure,” “recover from,” or “reverse” autism should be treated with extreme skepticism. Autism is a neurodevelopmental condition, not a disease to be cured. Effective, evidence-based supports exist — but miracle cures do not. Always discuss any treatment with your medical team before starting.
Specialty Centers & Referrals
- Huntsman Mental Health Institute (HMHI) — Autism Services: Part of University of Utah Health. Provides comprehensive diagnostic evaluations, psychiatric care, and behavioral health services for autistic individuals across the lifespan. Salt Lake City, UT. · 801-583-2500 · healthcare.utah.edu/hmhi
- University of Utah Neurobehavior HOME Program: Multidisciplinary autism evaluation and management for children and adults. Includes diagnostic assessment, medication management, and coordination of care. 240 E Morris Ave, 4th Floor, Salt Lake City, UT 84115 · 801-587-8020
- Primary Children’s Hospital — Developmental Pediatrics: Developmental evaluations, ASD diagnosis, and management of co-occurring conditions for children and adolescents. Part of Intermountain Health. Salt Lake City, UT. · 801-662-1000 · primarychildrens.org
- University of Utah Health (main): Academic medical center offering neurosciences, genetics, and pediatric subspecialties relevant to comprehensive ASD care. Salt Lake City, UT. · 801-581-2121
- Intermountain Health: System-wide developmental specialties and behavioral health services across the Mountain West region. · 801-442-2000 · intermountainhealth.org
- Utah Autism Academy of Learning (UAAL): A private school specifically designed for students on the autism spectrum, offering individualized academic and social-emotional programming. Multiple Utah locations. · utahautismacademy.org
- Marcus Autism Center (Emory University / Children’s Healthcare of Atlanta): One of the largest and most comprehensive autism centers in the US. Nationally recognized for early diagnosis, behavioral intervention research, and treatment of severe challenging behaviors. Atlanta, GA. · marcus.org
- TEACCH Autism Program (University of North Carolina at Chapel Hill): A pioneering clinical, training, and research program operating since 1972. Developed the TEACCH Structured Teaching approach used worldwide. Provides diagnostic, treatment, and consultation services. Chapel Hill, NC. · teacch.com
- Rady Children’s Hospital Autism Discovery Institute (San Diego): Integrates clinical care with cutting-edge research. Specializes in early detection, genomic approaches, and innovative therapies. San Diego, CA. · rchsd.org
- UC Davis MIND Institute: Leading research and clinical center for neurodevelopmental conditions including autism. Offers comprehensive diagnostic and treatment services. Sacramento, CA. · ucdmc.ucdavis.edu/mindinstitute
- Kennedy Krieger Institute (Johns Hopkins): Center for Excellence in Autism and related disorders. Inpatient and outpatient behavioral programs, diagnostic services, and research. Baltimore, MD. · kennedykrieger.org
- George E. Wahlen VA Medical Center: VA healthcare services in Salt Lake City. Veterans with autistic dependents or veterans themselves seeking adult ASD evaluation can access mental health, neurology, and psychology services through VA benefits. 500 Foothill Dr, Salt Lake City, UT 84148. · 801-582-1565 · va.gov/salt-lake-city-health-care
- VA Polytrauma/TBI System of Care: VA medical centers nationwide offer neurodevelopmental evaluations through their Mental Health and Neurology services. Veterans seeking an adult ASD evaluation should contact their local VA Mental Health clinic or request a referral through their VA primary care provider.
- CHAMPVA / TRICARE: Eligible dependents of veterans may access ASD diagnostic and therapy services, including ABA, through CHAMPVA or TRICARE coverage. Contact the applicable program for details on autism-specific benefits and referral requirements.
- Holland Bloorview Kids Rehabilitation Hospital (Toronto): Canada’s largest children’s rehabilitation hospital. Autism Research Centre provides diagnostic assessment, intervention, and family support. Toronto, ON. · 416-425-6220 · hollandbloorview.ca
- McMaster Children’s Hospital — Autism Spectrum Disorder Service (Hamilton): Comprehensive diagnostic and intervention services for children and adolescents. Part of Hamilton Health Sciences. Hamilton, ON. · 905-521-2100 · hamiltonhealthsciences.ca
- BC Children’s Hospital — Provincial Autism Assessment Program (Vancouver): Provincial referral center for complex autism diagnostic evaluation and interdisciplinary consultation. Vancouver, BC. · 604-875-2345 · bcchildrens.ca
- Montreal Children’s Hospital — Autism Spectrum Disorders Program (McGill): Bilingual (English/French) diagnostic and treatment services for ASD within the McGill University Health Centre network. Montreal, QC. · 514-412-4400 · thechildren.com
- Autism Canada: National advocacy organization providing resources, information, and support for autistic individuals and families across Canada. · autismcanada.org
- National Autistic Society (United Kingdom): The UK’s leading autism charity. Provides information, support services, campaigning, and training for autistic individuals and families. · autism.org.uk
- South London and Maudsley NHS Foundation Trust — National Autism Unit (UK): Specialist NHS assessment and treatment service for autistic adults with complex presentations. London, UK. · slam.nhs.uk
- Autism-Europe: International association connecting autism organizations across 40+ European countries. Advocates for the rights of autistic people, promotes best practices, and supports policy development. · autism-europe.org
- Karolinska Institutet — Center of Neurodevelopmental Disorders (KIND) (Sweden): Leading European research and clinical center for autism and ADHD. Contributes to international autism genetics and intervention research. Stockholm, Sweden. · ki.se
- National Center of Neurology and Psychiatry (NCNP) (Japan): Japan’s leading research and clinical facility for neurodevelopmental disorders, including autism spectrum disorder. Tokyo, Japan. · ncnp.go.jp
International Access & Regulatory Landscape
Autism spectrum disorder is recognized worldwide, but the regulatory frameworks governing diagnosis, approved therapies, and available supports differ substantially across regions. This section summarizes the current landscape in major jurisdictions to help families navigating international systems or relocating between countries.
The FDA has approved two medications specifically for irritability associated with ASD in children and adolescents: risperidone (ages 5–16, approved 2006) and aripiprazole (ages 6–17, approved 2009). No medication is approved for the core features of autism.
Behavioral interventions (ABA, speech therapy, OT) are regulated at the state level through professional licensing boards. Insurance mandates for autism coverage (including ABA) now exist in all 50 states, though scope and age limits vary. Medicaid coverage of autism services varies by state waiver programs.
The Autism CARES Act (most recently reauthorized in 2024) funds research, surveillance, and professional training through the NIH, CDC, and HRSA. The CDC’s ADDM Network provides the primary US prevalence surveillance data.
The European Medicines Agency (EMA) has not granted a specific autism indication for risperidone or aripiprazole at the EU-wide level, though both are used off-label in many member states for behavioral symptoms associated with ASD. Prescribing practices are governed by national regulatory authorities within each country.
The EU emphasizes inclusive education and community-based support under the European Disability Strategy 2021–2030. Access to behavioral therapies like ABA varies widely across member states — some countries (e.g., the Netherlands, Spain) have well-developed ABA services, while others have limited availability. Diagnostic practices generally follow ICD-11 criteria rather than DSM-5-TR.
The European Autism Strategy, adopted in 2024, calls for harmonized diagnostic pathways, equitable access to support services, and improved transition planning across EU member states.
NICE guidelines provide comprehensive frameworks for autism across the lifespan: CG128 (recognition, referral, and diagnosis in children and young people), CG170 (management and support for children and young people), and CG142 (diagnosis and management of autism in adults). These guidelines explicitly recommend against using antipsychotics for core autism features and advise that medication should be reserved for co-occurring conditions.
The NHS provides free diagnostic pathways through community assessment teams, though waiting times for assessment are often 12–24 months or longer. ABA is available privately but is not routinely commissioned by the NHS, which instead prioritizes speech and language therapy, occupational therapy, and social communication interventions such as the SCERTS model.
The Autism Act 2009 (England and Wales) was the first disability-specific legislation in the UK, requiring local authorities to develop autism strategies and diagnostic pathways for adults.
The Pharmaceuticals and Medical Devices Agency (PMDA) has approved aripiprazole for irritability associated with ASD in children and adolescents. Risperidone is used off-label. Japan uses the ICD system for diagnostic classification and commonly uses the umbrella term “developmental disorders” (hattatsu shōgai) in clinical and public discourse.
The Act on Support for Persons with Developmental Disabilities (2004, amended 2016) provides a legal framework for early detection, support services, and social inclusion. Prefectural developmental disability support centers offer diagnostic assessment and family support. ABA-based services are growing but remain less widely available than in the US; the Japanese Association for Behavior Analysis promotes evidence-based practice.
Health Canada has approved risperidone for behavioral disturbances in autism. Provincial and territorial governments are responsible for funding autism services, resulting in significant variation across the country. In 2023, the Canadian Autism Spectrum Disorder Alliance continued to advocate for a National Autism Strategy to address interprovincial disparities.
Provincial autism programs include: Ontario Autism Program (OAP), British Columbia Autism Assessment Network, Alberta Family Support for Children with Disabilities Act services, and Quebec’s Plan d’action sur le trouble du spectre de l’autisme. Wait times for publicly funded diagnostic assessment and intervention are a major concern nationwide.
The Therapeutic Goods Administration (TGA) has approved risperidone for behavioral disturbances in autism. The National Disability Insurance Scheme (NDIS) is the primary mechanism through which autistic Australians access funded therapy and support services, including ABA, speech therapy, OT, psychology, and support coordination.
The NDIS provides individualized funding packages based on assessed needs. The Autism CRC (Cooperative Research Centre for Living with Autism) has produced national guidelines for autism assessment and diagnosis, including the first Australian guideline for autistic adults. Autism is one of the most common primary disabilities funded through the NDIS.
- Diagnostic criteria: The US uses the DSM-5-TR; most other countries use the ICD-11. While both systems describe autism similarly, the ICD-11 retains sub-classifications (e.g., “autism with intellectual disability and functional language impairment”) not present in the DSM-5-TR.
- ABA availability: ABA is the dominant intervention model in the US and Canada. In the UK and many European countries, ABA is less widely adopted, with greater emphasis on developmental and relationship-based approaches (e.g., SCERTS, DIR/Floortime).
- Insurance mandates: All 50 US states mandate some form of autism insurance coverage. This level of legislated coverage does not exist in most other countries, where services are funded through national health systems or disability funding programs.
- Medication approvals: FDA approvals for ASD-associated irritability (risperidone, aripiprazole) are the most specific globally. Other agencies have more limited or different indication wording.
- Educational rights: IDEA in the US provides strong, enforceable educational rights with due process mechanisms. Other countries have varying levels of legal protection for inclusive education and specialized supports.
Failed & De-Adopted Therapies
Knowing what has been tried and did not work is important. The following therapies were once promoted, studied in clinical trials, or widely used for autism spectrum disorder but have been shown to be ineffective, harmful, or abandoned based on evidence. Understanding this history helps families avoid wasting time, money, and hope on disproven approaches.
Secretin is a gastrointestinal hormone that gained intense public attention in the late 1990s after a single case report suggested dramatic improvement in a child with autism following secretin infusion. Multiple randomized controlled trials (including studies by Owley et al. 2001, Sandler et al. 1999, and others) subsequently found no benefit over placebo for any autism-related outcome. At least 16 controlled trials have been published, none showing efficacy. Secretin infusion for autism is considered definitively disproven.
Chelation therapy (using agents like DMSA, DMPS, or EDTA to remove heavy metals from the body) was promoted based on the disproven hypothesis that mercury or other heavy metals cause autism. No controlled clinical trial has demonstrated benefit. A planned NIH trial (2008) was cancelled due to safety concerns, including risk of kidney failure, mineral depletion, cardiac arrhythmia, and death. The FDA has issued warnings against chelation products marketed for autism. Deaths have been reported from chelation therapy in children.
Facilitated Communication involves a “facilitator” physically supporting an individual’s hand or arm while they point to letters on a keyboard or letter board. Originally promoted as a breakthrough communication method, controlled studies consistently demonstrated that the facilitator — not the individual — was generating the messages (ideomotor effect). The American Speech-Language-Hearing Association (ASHA), the American Academy of Pediatrics, and the American Psychological Association have all issued position statements against FC. Its use has led to false allegations and family separations. FC should not be confused with legitimate AAC methods where the individual independently selects communication symbols.
Balovaptan was developed by Roche as a vasopressin V1a receptor antagonist intended to improve social communication in autism. Despite promising Phase II results, the pivotal Phase III V1aduct trial in adults with ASD did not meet its primary endpoint for improving social communication or interaction (the separate pediatric aV1ation trial also failed). Roche discontinued clinical development for this indication. The drug received FDA Breakthrough Therapy designation in 2018, which was based on earlier-phase data that did not replicate in the larger trial.
Bumetanide is a loop diuretic hypothesized to reduce intracellular chloride concentrations and restore GABA inhibition in the brain. Early open-label and small controlled studies suggested potential benefit for core ASD symptoms. However, the large Phase III SIGN trials in Europe (NCT03715153 and related studies) failed to meet their primary endpoints. Servier and Neurochlore announced discontinuation of the ASD development program based on these results. Side effects include dehydration and electrolyte imbalances requiring monitoring.
Oxytocin, sometimes called the “social hormone,” was studied extensively as a potential treatment for social communication difficulties in autism. The largest and most rigorous trial — the SOARS-B study (Duke/UNC-led ACE network, NCT01944046) — found no significant benefit of intranasal oxytocin over placebo on primary social outcome measures after 24 weeks of treatment. Earlier, smaller studies had produced mixed results. Intranasal oxytocin is not recommended for autism outside of research settings.
Auditory Integration Training involves listening to electronically modified music through headphones, purportedly to retrain auditory processing. Several methods exist (Bérard AIT, Tomatis method). Systematic reviews have found insufficient evidence to support its use for autism. The American Academy of Pediatrics does not recommend AIT as an established treatment for autism. While not harmful, it is expensive and diverts time and resources from evidence-based interventions. AIT has largely fallen out of mainstream clinical practice, though it continues to be offered by some private practitioners.
- ADOS-2 (Autism Diagnostic Observation Schedule, 2nd Edition): The gold-standard observational assessment tool for diagnosing autism. A trained clinician engages the individual in structured and semi-structured activities to observe social communication, interaction, and behavior patterns.
- ADI-R (Autism Diagnostic Interview — Revised): A comprehensive, structured interview conducted with a parent or caregiver, covering the individual’s developmental history, communication, social interaction, and restricted/repetitive behaviors.
- ABA (Applied Behavior Analysis): A widely used, evidence-based therapy that applies principles of learning and motivation to teach new skills and reduce challenging behaviors. Modern ABA emphasizes naturalistic teaching, child choice, and functional skill development.
- ESDM (Early Start Denver Model): A naturalistic developmental behavioral intervention for children aged 12–48 months. Combines behavioral teaching strategies with developmental and relationship-based approaches delivered through play.
- JASPER (Joint Attention, Symbolic Play, Engagement & Regulation): A targeted intervention focused on building joint attention and play skills. Developed at UCLA with strong evidence from multiple randomized trials. Can be delivered by therapists or trained parents.
- IEP (Individualized Education Program): A legally binding document developed under IDEA that outlines the educational goals, services, accommodations, and placement for a student with a disability in public school.
- 504 Plan: An accommodation plan under Section 504 of the Rehabilitation Act. Less comprehensive than an IEP but still legally enforceable. Provides modifications and accommodations to ensure equal access to education.
- IDEA (Individuals with Disabilities Education Act): The federal law guaranteeing a Free Appropriate Public Education (FAPE) for children with disabilities from birth through age 21, including the right to special education services and an IEP.
- Masking / camouflaging: The conscious or unconscious suppression of autistic traits and behaviors in order to fit in with social expectations. Common in autistic women and girls. Prolonged masking is associated with mental health difficulties, exhaustion, and autistic burnout.
- Stimming (self-stimulatory behavior): Repetitive movements, sounds, or actions such as hand-flapping, rocking, spinning, humming, or tapping. Stimming serves important functions including self-regulation, sensory input, emotional expression, and stress relief. It is a natural part of being autistic.
- Executive function: A set of cognitive processes that enable planning, organization, working memory, flexible thinking, impulse control, and task initiation. Many autistic individuals experience executive function challenges, which can affect daily living, academic performance, and employment.